The RNA world hypothesis posits that molecules made up of ribonucleic acids (RNA) are responsible for kickstarting evolution ...
Purdue University researcher Andrea Kasinski is leading work on the relationship between microRNAs — small, non-coding segments of RNA — and cancer, including developing a modified microRNA that curbs ...
WEST LAFAYETTE, Ind. — Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to grow and spread, a substantial advantage over even ...
A strand of RNA just 45 nucleotides long can copy its own complementary sequence in frozen conditions that may resemble early ...
These advances, still under investigation, hold the promise of revolutionizing healthcare for future colorectal cancer ...
Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...
Researchers at University College Dublin have discovered a previously unknown "courier system" that cells use to deliver ...
Quarterly RNA drug plozasiran turns off a liver gene, sharply lowering life‑threatening pancreatitis attacks in a rare ...
Storm Therapeutics has closed a $56 million series C financing as the British biotech kicks off a phase 2 sarcoma trial of ...
The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indicationsFirst‑in‑class METTL3 inhibitor reprograms ...
RNA therapies present significant opportunities in targeting a broad range of diseases through various innovative approaches, including antisense oligonucleotides, siRNAs, mRNA vaccines, and aptamers.